Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models

Chew NJ, Lim Kam Sian TCC, Nguyen EV, Shin SY, Yang J, Hui MN, Deng N, McLean CA, Welm AL, Lim E, Gregory P, Nottle T, Lang T, Vereker M, Richardson G, Kerr G, Micati D, Jardé T, Abud HE, Lee RS, Swarbrick A, Daly RJ

(2021), Breast Cancer Res, 23(1), 82

DOI: 10.1186/s13058-021-01461-4

Biallelic hypomorphic variants in ALDH1A2 cause a novel lethal human multiple congenital anomaly syndrome encompassing diaphragmatic, pulmonary, and cardiovascular defects

Beecroft SJ, Ayala M, McGillivray G, Nanda V, Agolini E, Novelli A, Digilio MC, Dotta A, Carrozzo R, Clayton J, Gaffney L, McLean CA, Ng J, Laing NG, Matteson P, Millonig J, Ravenscroft G

(2021), Hum Mutat, 42(5), 506-19

DOI: 10.1002/humu.24179

Misclassification of calcium status in end-stage kidney disease using albumin-adjusted calcium levels

Law MM, Smith JD, Schneider HG, Wilson S

(2021), Nephrology, 26(9), 725-32

DOI: 10.1111/nep.13910

Report of the Survey Conducted by RCPAQAP on Current Practices for Beta-Migrating Paraprotein Reporting

Smith JD, Wijeratne N, Schneider HG, de Malmanche T, Hissaria P, Toit SD, Chiu W, Boyder C, Morison IM, Tseng A, Glegg K, Wienholt L, Mollee P

(2021), The Clinical Biochemist Reviews, 42(1), 11-6

DOI: 10.33176/AACB-21-00001

Aetiologies and factors associated with poor clinical outcomes in rhabdomyolysis: a retrospective cohort study in an Australian trauma centre

Khu YL, Lewis B, Blackshaw L, Tan SMQ, Bayfield A, Schneider HG, Liew D, Aung AK

(2021), Intern Med J, 51(2), 264-7

DOI: 10.1111/imj.15183

Urine toxicology screening by liquid chromatography time-of-flight mass spectrometry in a quaternary hospital setting

Pope JD, Black MJ, Drummer OH, Schneider HG

(2021), Clin Biochem, 95, 66-72

DOI: 10.1016/j.clinbiochem.2021.05.004

Myeloid somatic mutation panel testing in myeloproliferative neoplasms

Ross DM, Thomson C, Hamad N, Lane SW, Manos K, Grigg AP, Guo B, Erber WN, Scott A, Viiala N, Chee L, Latimer M, Tate C, Grove C, Perkins AC, Blombery P

(2021), Pathology, 53(3), 339-48

DOI: 10.1016/j.pathol.2021.01.003

The impact of incomplete clinical information and initial biopsy technique on the histopathological diagnosis of cutaneous melanoma

Kok Y, Scott K, Pham A, Liu W, Roberts H, Pan Y, McLean C, Chamberlain A, Kelly JW, Mar VJ

(2021), Australas J Dermatol, 62(4), e524-31

DOI: 10.1111/ajd.13697

Prospective surveillance for invasive Staphylococcus aureus and group A Streptococcus infections in a setting with high community burden of scabies and impetigo

Thean LJ, Jenney A, Engelman D, Romani L, Wand H, Mani J, Paka J, Cua T, Taole S, Soqo V, Sahukhan A, Kama M, Tuicakau M, Kado J, Carvalho N, Whitfeld M, Kaldor J, Steer AC

(2021), Int J Infect Dis, 108, 333-9

DOI: 10.1016/j.ijid.2021.05.041

Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study

von Mollendorf C, Ulziibayar M, Gessner BD, Do LAH, Nguyen CD, Beavon R, Suuri B, Luvsantseren D, Narangerel D, Jenney A, Dunne EM, Satzke C, Darmaa B, Mungun T, Mulholland EK

(2021), BMC Public Health, 21(1), 1731

DOI: 10.1186/s12889-021-11776-8

Early antimicrobial stewardship team intervention on appropriateness of antimicrobial therapy in suspected sepsis: a randomized controlled trial

Rashidzada Z, Cairns KA, Peel TN, Jenney AW, Doyle JS, Dooley MJ, Cheng AC

(2021), JAC Antimicrobial Resistance, 3(3), dlab097

DOI: 10.1093/jacamr/dlab097

Silent spread of mobile colistin resistance gene mcr-9.1 on IncHI2 'superplasmids' in clinical carbapenem-resistant Enterobacterales

Macesic N, Blakeway LV, Stewart JD, Hawkey J, Wyres KL, Judd LM, Wick RR, Jenney AW, Holt KE, Peleg AY

(2021), CLIN MICROBIOL INFEC, 27(12), 1856.e7-1856.e13

DOI: 10.1016/j.cmi.2021.04.020

Genotype Diversity before and after the Introduction of a Rotavirus Vaccine into the National Immunisation Program in Fiji

Thomas S, Donato CM, Covea S, Ratu FT, Jenney AWJ, Reyburn R, Sahu Khan A, Rafai E, Grabovac V, Serhan F, Bines JE, Russell FM

(2021), Pathogens, 10(3), 358

DOI: 10.3390/pathogens10030358

Prospective Surveillance of Primary Healthcare Presentations for Scabies and Bacterial Skin Infections in Fiji, 2018-2019

Thean LJ, Romani L, Engelman D, Jenney A, Wand H, Mani J, Paka J, Devi R, Sahukhan A, Kama M, Tuicakau M, Kado J, Carvalho N, Whitfeld M, Kaldor J, Steer AC

(2021), Am J Trop Med Hyg, 105(1), 230-7

DOI: 10.4269/ajtmh.20-1459

Genomic surveillance of antimicrobial resistant bacterial colonisation and infection in intensive care patients

Wyres KL, Hawkey J, Mirčeta M, Judd LM, Wick RR, Gorrie CL, Pratt NF, Garlick JS, Watson KM, Pilcher DV, McGloughlin SA, Abbott IJ, Macesic N, Spelman DW, Jenney AWJ, Holt KE

(2021), BMC Infect Dis, 21(1), 683

DOI: 10.1186/s12879-021-06386-z

Development and piloting of a prevention assessment and response tool for healthcare-associated Staphylococcus aureus bloodstream infection (the SAB-PART Study) using a Delphi method

Karanfilovska D, Cheng AC, Spelman D, Worth LJ

(2021), J Hosp Infect, 115, 17-26

DOI: 10.1016/j.jhin.2021.06.001

Group A streptococcal bacteraemia at a tertiary hospital in Melbourne: concern of an under-reported risk group in Australia

Attwood LO, Spelman D

(2021), Intern Med J, 51(4), 565-70

DOI: 10.1111/imj.14807

Successful treatment of disseminated Mycobacterium simiae infection in a patient with advanced HIV

Ashok A, Hoy J, Spelman D, McMahon J, Pai Mangalore R

(2021), AIDS, 35(1), 157-8

DOI: 10.1097/QAD.0000000000002702

Disseminated intraosseous Kaposi's sarcoma: A rare manifestation of HIV/AIDS

Narita C, Lukies M, Tay HS, Marovic P

(2021), J MED IMAG RADIAT ON, 65(1), 86-8

DOI: 10.1111/1754-9485.13112

Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia

Tiong IS, Dillon R, Ivey A, Kuzich JA, Thiagarajah N, Sharplin KM, Kok CH, Tedjaseputra A, Rowland JP, Grove CS, Abro E, Shortt J, Hiwase DK, Bajel A, Potter NE, Smith ML, Hemmaway CJ, Thomas A, Gilkes AF, Russell NH, Wei AH

(2021), Blood Adv, 5(23), 5107-111

DOI: 10.1182/bloodadvances.2021005455

1 2 3 4 5